Asensus Surgical, Inc.

Equities

ASXC

US04367G1031

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:00 2024-04-15 pm EDT 5-day change 1st Jan Change
0.275 USD +1.48% Intraday chart for Asensus Surgical, Inc. +3.70% -13.77%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Investors on -2- DJ
HC Wainwright Downgrades Asensus Surgical to Neutral From Buy, Adjusts PT to $0.35 From $2 MT
Sector Update: Health Care Stocks Softer Late Afternoon MT
Sector Update: Health Care Stocks Rise Wednesday Afternoon MT
Asensus Surgical Shares Soar After KARL STORZ Acquisition Offer Announcement MT
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million. CI
Asensus Surgical, Inc. announced that it has received $20 million in funding CI
Asensus Surgical, Inc. Announces Impairment Charges for the Fourth Quarter Ended December 31, 2023 CI
Asensus Surgical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Asensus Surgical, Inc., Q4 2023 Earnings Call, Mar 21, 2024
Earnings Flash (ASXC) ASENSUS SURGICAL Reports Q4 Revenue $5.4M, vs. Street Est of $5.5M MT
Asensus Surgical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Investors -2- DJ
Transcript : Asensus Surgical, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 12:00 PM
Asensus Surgical Preliminary Q4 Revenue Tops Estimates; Shares Rise MT
Asensus Surgical, Inc. Provides Unaudited Earnings Guidance for the Quarter and Full Year Ending on December 31, 2023 CI
Asensus Surgical, Inc. Develops the LUNA Surgical System CI
Cantor Fitzgerald Downgrades Asensus Surgical to Neutral From Overweight MT
Transcript : Asensus Surgical, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Earnings Flash (ASXC) ASENSUS SURGICAL Posts Q3 Revenue $1.1M MT
Asensus Surgical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Asensus Surgical Sells Senhance Surgical System to Distribution Partner MT
Certain Restricted Stock Units of Asensus Surgical, Inc. are subject to a Lock-Up Agreement Ending on 25-SEP-2023. CI
Certain Warrants of Asensus Surgical, Inc. are subject to a Lock-Up Agreement Ending on 25-SEP-2023. CI
Certain Options of Asensus Surgical, Inc. are subject to a Lock-Up Agreement Ending on 25-SEP-2023. CI
Chart Asensus Surgical, Inc.
More charts
Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.275 USD
Average target price
0.35 USD
Spread / Average Target
+27.27%
Consensus
  1. Stock Market
  2. Equities
  3. ASXC Stock
  4. News Asensus Surgical, Inc.
  5. Asensus Surgical Says FDA Clears Expanded Indication for Senhance System